
Johnson & Johnson CEO stated that curing certain cancers within a decade is a realistic goal. The executive expressed confidence in the company's pipeline and scientific progress toward this objective. The timeline reflects an ambitious target for oncology treatments.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Johnson & Johnson CEO on Cancer, AI, Medical Innovation